-+ 0.00%
-+ 0.00%
-+ 0.00%

Opus Genetics reports initial Phase 1/2 OPGx-BEST1 gene therapy data in BEST1 retinal disease

Reuters·02/27/2026 15:10:15

Please log in to view news